ONE-WAYDated event · through FY2022
Strengthening the anticancer drug and Asian businesses through a capital and business alliance with Lotus Pharmaceutical
A theme focused on strengthening the Japanese anticancer drug business through a capital and business alliance with Lotus Pharmaceutical, complementing each other’s pharmaceutical manufacturing and sales operations in Asia, particularly ASEAN, and advancing joint development, regulatory applications and global expansion.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2019-Q2 →Last written FY2022
Directionhelps1 helps · 0 hurts · 0 flat